Enter assignee name

Forward Citations = 235

Loading Chart...

5 inventors (with patents filed for the assignee):

Jeffrey A Ledbetter (4 out of 81 patents)

Martha Susan Hayden-Ledbetter (4 out of 31 patents)

Peter Armstrong Thompson (1 out of 9 patents)

4. Peter Robert Baum (1 out of 31 patents)

5. Erik Stephen Espling (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 7846434 - Materials and methods for improved immunoglycoproteins (2010-12-07),

2. 7829084 - Binding constructs and methods for use thereof (2010-11-09),

3. 7754209 - Binding constructs and methods for use thereof (2010-07-13),

4. 7754208 - Binding domain-immunoglobulin fusion proteins (2010-07-13),

5. 7118751 - DNA vaccines encoding antigen linked to a domain that binds CD40 (2006-10-10),

Trubion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of autoimmune and inflammatory diseases. The company's lead product candidate, TRU-016, is currently in clinical development for the treatment of lymphoma and leukemia. Trubion's innovative approach to drug development includes the use of proprietary technologies to target specific disease pathways with the goal of improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#340 in Seattle, WA

#1,194 in Washington

#50,255 in US

Seattle, WA, United States of America

Trubion Pharmaceuticals, Inc.